GLP-1 medications , or glucagon-like peptide-1 receptor agonists , are injectable drugs commonly prescribed for type 2 diabetes and weight management
Its the same logic here. That said, a minority of patients manage to stop and maintain their weight loss
Some GLP-1 medications are available as oral tablets, which dont cause the injection site reactions common to injectable GLP-1s
Reta Support does not provide dosing, sourcing, or medication-use guidance
Health professionals in weight loss clinics may suggest them as part of an overall health plan aimed at reducing medical expenses due to obesity-related issues
Tirzepatide is a dual GLP-1 and GIP receptor agonist , meaning it mimics two hormones, working even more comprehensively to manage appetite and metabolism